DGAP-News
SHOP APOTHEKE EUROPE grows more than twice as fast as the overall Continental European market in 2016. Accelerated growth projected for 2017 as well.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Final Results/Forecast
|
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN.
SHOP APOTHEKE EUROPE grows more than twice as fast as the overall Continental European market in 2016. Accelerated growth projected for 2017 as well.
- Revenues increased by 41% to EUR 177.4 million in 2016
-
- Gross margin stable at 20.5% despite accelerated growth; adjusted EBITDA margin improved from -4.2% to -3.3%
-
- Long-term loans repaid as planned with proceeds from the IPO
-
- Revenues from international operations more than tripled to EUR 30.4 million thanks to the early integration of FARMALINE that was acquired in September 2016
-
- Profitability in the German core market grew while revenues increased by 26%
-
- Excellent start into the 2017 fiscal year; accelerated growth and further improvements in profitability expected
-
Venlo, the Netherlands, March 27, 2017 - SHOP APOTHEKE EUROPE N.V., Europe's leading online OTC pharmacy (OTC = over the counter = non-prescription medications), has achieved its ambitious 2016 growth targets. With corporate revenues increasing by over 41% to EUR 177.4 million (previous year: EUR 125.6 million), SHOP APOTHEKE EUROPE grew more than twice as fast as the overall Continental European market, which went up 17%*. Strong growth in international revenues - boosted by the rapid integration of the FARMALINE online pharmacy acquired in September 2016 - has further accelerated growth and strengthened SHOP APOTHEKE EUROPE's leading position in the dynamically growing European online pharmacy market.